News

Medidata announced that BeiGene, a clinical-stage biopharmaceutical company developing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, will expand…
Read More...

Pfizer Inc. and Basilea Pharmaceutica announced that they have completed the licensing agreement whereby Pfizer has obtained the exclusive commercialization rights in Europe to CRESEMBA…
Read More...

Oncology Venture AB and Novartis Pharma AG (Basel, Switzerland) have entered into an agreement providing Oncology Venture with an option right to  execute an exclusive license to…
Read More...

ModGene Pharma announced the issuance of US Patent 9,707,231, entitled "Compositions and Methods for Reduction of Amyloid-beta Load." The claims cover the use of an imatinib-related…
Read More...

Amgen and UCB announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologics License Application (BLA) for EVENITY (romosozumab) as a…
Read More...

Valeant Pharmaceuticals International announced that certain affiliates of the Company have entered into an agreement to sell its Obagi Medical Products business for $190 million in…
Read More...

Glenmark Pharmaceuticals, a global pharmaceutical company, announced that it has entered into a development, license, manufacture and commercial supply agreement with Cyndea Pharma…
Read More...

Roche announced that OCREVUS (ocrelizumab) has been approved by the Australian Therapeutic Goods Administration (TGA) for the treatment of relapsing forms of multiple sclerosis (RMS)…
Read More...

Eli Lilly and Company has entered into a settlement agreement with generic companies to resolve pending patent litigation in the U.S. District Court for the Eastern District of Virginia…
Read More...

Biognosys announced that it has secured USD 5m funding from new and existing investors in an extended series C round. Biognosys’ contract research services and tools are successfully…
Read More...

Lannett Company announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Cyproheptadine Hydrochloride…
Read More...

Following the recent launch by the publishers of the British National Formulary (BNF) and British National Formulary for children (BNFC) of a new, faster, easier to use and access app,…
Read More...

Viamet Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to VT-1598, a novel oral agent for the treatment of…
Read More...

In a new collaboration, ShangPharma Innovation, Inc. (SPII) is providing funding and other support to scientists at UC San Francisco (UCSF) to accelerate the development of promising…
Read More...

Allena Pharmaceuticals, Inc., a specialty biopharmaceutical company dedicated to bringing first in class, specific, non-absorbed, oral protein therapeutics to patients with serious…
Read More...

Sanofi announced it will acquire Protein Sciences, a privately held vaccines biotechnology company based in Meriden, Connecticut in the United States. Under the terms of the agreement,…
Read More...

BioDelivery Sciences International, Inc., a specialty pharmaceutical company with a focus in pain management and addiction medicine, and Purdue Pharma (Canada) announce that they have…
Read More...

Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has signed a licensing agreement and a…
Read More...

CURE Pharmaceutical, a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company and Therapix Biosciences, a specialty clinical-stage…
Read More...

InMed Pharmaceuticals, Inc., a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, is pleased to announce it has entered…
Read More...